Jun 07 2010
HOUSTON, Texas—- Essex Woodlands Health Ventures (www.ewhv.com), a leading venture capital/growth equity firm dedicated to health care investing, announces the appointment of George W. Carmany, III as a Senior Advisor. Having expanded capital under management to $2.5 billion, Essex Woodlands continues to expand its elite management team with the addition of Mr. Carmany. Mr. Carmany began his business career with Bankers Trust Company in its International Banking Department, working in New York, followed by four years in Sydney, Australia as the Executive Director of its merchant banking subsidiary. His career at American Express spans nearly two decades, from 1975 when he held senior positions at the corporate level and in its international banking division, including Senior Vice President, Corporate Strategic Planning and Senior Executive Vice President, to his leadership as Principal Administrative Officer of American Express’ investment management and private banking subsidiary, The Boston Company, until the sale of the company to Mellon Financial Corporation in 1993. His experience extends to virtually every aspect of the investment banking and biotech industry including the formation of G.W.Carmany and Company, an advisory business in financial services and life sciences.
Mr. Carmany is a Director of the Macquarie Infrastructure Company. He also served internationally as Director of Sun Life Financial in Toronto, Canada, is Senior Advisor to EnGeneIC Pty.Ltd., a biotechnology company in Sydney, Australia , and is a Senior Advisor to Brown Brothers Harriman and Company, and The Asia Link Group of Beijing, PRC. He served as CEO and Chairman of Helicon Therapeutics, a biotechnology company founded by the Cold Spring Laboratory, Roche Pharmaceuticals and OSI Pharmaceuticals until 2005. Mr. Carmany is the past Chairman of The New England Medical Center; a Trustee and member of the Executive Committee of Bentley University; a member of the Executive Committee of the Alumni Council of Amherst College; and past Chairman of the Board of Associates of The Whitehead Institute for Biomedical Research.
In describing his decision to join Essex Woodlands, Mr. Carmany said, “Throughout its 25 year history Essex Woodlands has been a highly successful healthcare investment firm due to the strength of its partnerships with entrepreneurs and investors alike. Healthcare reform now introduces new opportunities and challenges, which Essex Woodlands is well equipped to manage due to the knowledge, vision and abilities of its professional management team. I am delighted to join this firm in this unique capacity to contribute to its future investments and participate in providing successful returns to its limited partners”.
Mr. Carmany maintains his office in Boston, where he is an active member of the local medical community.
Marty Sutter, Co-Founder and Managing Director of Essex Woodlands, said of his appointment: “George Carmany is a highly experienced corporate finance executive and business strategist, and extraordinarily well-regarded in the life sciences community. We are honored that he has chosen to join our team and look forward to working with him in the exciting years ahead”.